Biotech · Private company
OmicsWay Corp.
Track this companyFree. Adds OmicsWay Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- ChemotherapyHER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- non-target drugCancerClinicalTrials.gov · fetched Nov 12, 2026
- palliative careCancerClinicalTrials.gov · fetched Nov 12, 2026
- RNA sequencingCancerClinicalTrials.gov · fetched Nov 12, 2026
- RNA sequencingHER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- target drug with the score above 0,1CancerClinicalTrials.gov · fetched Nov 12, 2026
- target drug with the score equal or below 0,1CancerClinicalTrials.gov · fetched Nov 12, 2026
- Transcriptome analysisCancerClinicalTrials.gov · fetched Nov 12, 2026
- Transcriptome analysisHER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabHER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Identification of Molecular Biomarkers for Cancer Target Therapy EfficacyUNKNOWN · started Oct 17, 2017ClinicalTrials.gov NCT03724097 · fetched Nov 12, 2026
- Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast CancerUNKNOWN · started Oct 1, 2017ClinicalTrials.gov NCT03521245 · fetched Nov 12, 2026